A novel strategy for combating multidrug-resistant bacteria: Natural products from uncultured microorganisms.

The emergence of bacterial resistance has severely compromised the efficacy of antibiotics, creating an urgent public health crisis. Regrettably, conventional natural products (NPs), nature's primary reservoir for antibiotic discovery, are being exhausted due to overexploitation, leading to a concerning scarcity of developable NPs. There is an urgent need for new strategies to combat infections caused by drug-resistant bacteria. Of particular significance is the emerging recognition that the uncultured microbial majority in natural environments may synthesize antimicrobial compounds with unprecedented structural motifs and functional attributes capable of bypassing existing cross-resistance patterns, thereby maintaining potency against resistant pathogens-a revelation that reinvigorates the therapeutic pipeline with newfound optimism. Here, this review comprehensively and systematically expounds the newest methods for cultivating uncultured microorganisms and the action mechanisms of antibiotics from uncultured microorganisms in recent years. These antibiotics effectively bypass the multidrug resistance barrier, demonstrate excellent antibacterial activity, and show minimal resistance at present. Furthermore, they have served as novel chemical scaffolds for the development of numerous derivatives with good antibacterial activity. In summary, these antibiotics are highly unique, indicating strong potential for development and application. The NPs from uncultured microorganisms hold a great promise in addressing the issue of antibiotic resistance, providing strategic directions for the development of novel antimicrobial drugs and alleviating the resistance crisis.

• Publication year

  2025

• Venue

  European journal of medicinal chemistry

• Publication date

  2025-09-01

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/j.ejmech.2025.118119PMID 40939497
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microbial secondary metabolites: advancements to accelerate discovery towards application

  2025cited by this paper
• The global resistance problem and the clinical antibacterial pipeline

  2025cited by this paper
• Chemoenzymatic Synthesis and Protein Engineering Enable Efficient, Scalable Production of Teleocidin Derivatives.

  2025cited by this paper
• Vancomycin–Teixobactin Conjugates

  2025cited by this paper
• Clinical-type dextran: A review on process and enzyme engineering strategies to control molecular weight distribution.

  2025cited by this paper
• Sophisticated natural products as antibiotics

  2024cited by this paper
• Dual‐Mechanism Peptide SR25 has Broad Antimicrobial Activity and Potential Application for Healing Bacteria‐infected Diabetic Wounds

  2024cited by this paper
• Discovery of antimicrobial peptides in the global microbiome with machine learning.

  2024cited by this paper
• TRYing to evaluate production costs in microbial biotechnology.

  2024cited by this paper
• Two co-dependent routes lead to high-level MRSA

  2024cited by this paper
• The pearl jubilee of microcin J25: thirty years of research on an exceptional lasso peptide.

  2024cited by this paper
• In Vivo Activity Profiling of Biosynthetic Darobactin D22 against Critical Gram-Negative Pathogens

  2024cited by this paper
• A new class of antibiotics is cause for cautious celebration — but the economics must be fixed

  2024cited by this paper
• Empirical economic analysis shows cost-effective continuous manufacturing of cultivated chicken using animal-free medium

  2024cited by this paper
• Divergent Total Synthesis and Characterization of Maxamycins.

  2023cited by this paper
• Darobactin B Stabilises a Lateral‐Closed Conformation of the BAM Complex in E. coli Cells

  2023cited by this paper
• Darobactin B Stabilises a Lateral‐Closed Conformation of the BAM Complex in E. coli Cells

  2023cited by this paper
• Resurrecting ancestral antibiotics: unveiling the origins of modern lipid II targeting glycopeptides

  2023cited by this paper
• New Genetically Engineered Derivatives of Antibacterial Darobactins Underpin Their Potential for Antibiotic Development

  2023cited by this paper
• Inhibitors targeting BamA in gram-negative bacteria.

  2023cited by this paper
• Development of teixobactin analogues containing hydrophobic, non-proteogenic amino acids that are highly potent against multidrug-resistant bacteria and biofilms.

  2023cited by this paper
• Biosynthesis of Phomactin Platelet Activating Factor Antagonist Requires a Two-Enzyme Cascade.

  2023cited by this paper
• Uncultured prokaryotic genomes in the spotlight: An examination of publicly available data from metagenomics and single-cell genomics

  2023cited by this paper
• An antibiotic from an uncultured bacterium binds to an immutable target.

  2023cited by this paper
• A new antibiotic from an uncultured bacterium binds to an immutable target

  2023cited by this paper
• HAS 1: A natural product from soil-isolated Streptomyces species with potent activity against cutaneous leishmaniasis caused by Leishmania tropica

  2022cited by this paper
• The pathogenic mechanism of Mycobacterium tuberculosis: implication for new drug development

  2022cited by this paper
• Bioprospecting for Novel Bacterial Sources of Hydrolytic Enzymes and Antimicrobials in the Romanian Littoral Zone of the Black Sea

  2022cited by this paper
• Isobactins: O-acyl isopeptide prodrugs of teixobactin and teixobactin derivatives

  2022cited by this paper
• Secondary Metabolites Produced by Plant Growth-Promoting Bacterial Endophytes

  2022cited by this paper
• Modelling intermediates of BamA folding an outer membrane protein.

  2022cited by this paper
• Teixobactin kills bacteria by a two-pronged attack on the cell envelope

  2022cited by this paper
• Natural products and their semi-synthetic derivatives against antimicrobial-resistant human pathogenic bacteria and fungi

  2022cited by this paper
• Visualizing the mode of action and supramolecular assembly of teixobactin analogues in Bacillus subtilis

  2022cited by this paper
• Comparative Analysis of Gut Microbiota in Captive and Wild Oriental White Storks: Implications for Conservation Biology

  2021cited by this paper
• Mutasynthetic Production and Antimicrobial Characterization of Darobactin Analogs

  2021cited by this paper
• Improved broad-spectrum antibiotics against Gram-negative pathogens via darobactin biosynthetic pathway engineering

  2021cited by this paper
• β-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates.

  2021cited by this paper
• Biosynthetic potential of uncultured Antarctic soil bacteria revealed through long-read metagenomic sequencing

  2021cited by this paper
• Strategies for Natural Products Discovery from Uncultured Microorganisms

  2021cited by this paper
• A Comprehensive Review on Pharmacology of Efflux Pumps and their Inhibitors in Antibiotic Resistance.

  2021cited by this paper
• Cultivation of uncultured marine microorganisms

  2021cited by this paper
• Triggering Growth via Growth Initiation Factors in Nature: A Putative Mechanism for in situ Cultivation of Previously Uncultivated Microorganisms

  2021cited by this paper
• Natural products research in the modern age

  2020cited by this paper
• Mode of action of teixobactins in cellular membranes

  2020cited by this paper
• Novel Antimicrobials from Uncultured Bacteria Acting against Mycobacterium tuberculosis

  2020cited by this paper
• The Science of Antibiotic Discovery.

  2020cited by this paper
• Acyldepsipeptide Antibiotics and a Bioactive Fragment Thereof Differentially Perturb Mycobacterium tuberculosis ClpXP1P2 Activity in vitro.

  2020cited by this paper
• Characterization of Metagenome-Assembled Genomes and Carbohydrate-Degrading Genes in the Gut Microbiota of Tibetan Pig

  2020cited by this paper
• Discovery of Novel Biosynthetic Gene Cluster Diversity From a Soil Metagenomic Library

  2020cited by this paper
• A genomic catalog of Earth’s microbiomes

  2020cited by this paper
• Strategies for culturing active/dormant marine microbes

  2020cited by this paper
• Target identification and validation of natural products with label-free methodology: A critical review from 2005 to 2020.

  2020cited by this paper
• Antimicrobials Misuse/Overuse: Adverse Effect, Mechanism, Challenges and Strategies to Combat Resistance

  2020cited by this paper
• Targeted isolation and cultivation of uncultivated bacteria by reverse genomics

  2019cited by this paper
• Renaissance of Vancomycin: Approaches for Breaking Antibiotic-Resistance in Multidrug-Resistant Bacteria.

  2019cited by this paper
• The hidden enzymology of bacterial natural product biosynthesis

  2019cited by this paper
• Antibiotic discovery: history, methods and perspectives.

  2019cited by this paper
• A new antibiotic selectively kills Gram-negative pathogens

  2019cited by this paper
• Design, Synthesis, and Study of Lactam and Ring-Expanded Analogues of Teixobactin.

  2019cited by this paper
• BamA is a pivotal protein in cell envelope synthesis and cell division in Deinococcus radiodurans.

  2019cited by this paper
• Antibiotics: past, present and future.

  2019cited by this paper
• New insights from uncultivated genomes of the global human gut microbiome

  2019cited by this paper
• The majority is uncultured

  2018cited by this paper
• The Tripod for Bacterial Natural Product Discovery: Genome Mining, Silent Pathway Induction, and Mass Spectrometry-Based Molecular Networking

  2018cited by this paper
• Single-cell metagenomics: challenges and applications

  2018cited by this paper
• Culturing the human microbiota and culturomics

  2018cited by this paper
• Phylogenetically Novel Uncultured Microbial Cells Dominate Earth Microbiomes

  2018cited by this paper
• GABA Modulating Bacteria of the Human Gut Microbiota

  2018cited by this paper
• Investigating the Biosynthesis of Natural Products from Marine Proteobacteria: A Survey of Molecules and Strategies

  2017cited by this paper
• Quinones are growth factors for the human gut microbiota

  2017cited by this paper
• Effects of engineered nanoparticles on the innate immune system.

  2017cited by this paper
• Cultured microbes represent a substantial fraction of the human and mouse gut microbiota

  2017cited by this paper
• Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options

  2017cited by this paper
• Converting Teixobactin into a Cationic Antimicrobial Peptide (AMP).

  2017cited by this paper
• Towards Selective Mycobacterial ClpP1P2 Inhibitors with Reduced Activity against the Human Proteasome

  2017cited by this paper
• Vancomycin Resistance in Staphylococcus aureus


  2017cited by this paper
• The trajectory of microbial single-cell sequencing

  2017cited by this paper
• Omics-based natural product discovery and the lexicon of genome mining.

  2017cited by this paper
• Interactions between the microbiota, immune and nervous systems in health and disease

  2017cited by this paper
• Natural Products as Platforms To Overcome Antibiotic Resistance.

  2017cited by this paper
• The evolution of genome mining in microbes - a review.

  2016cited by this paper
• Culturing of ‘unculturable’ human microbiota reveals novel taxa and extensive sporulation

  2016cited by this paper
• Lipid-II Independent Antimicrobial Mechanism of Nisin Depends On Its Crowding And Degree Of Oligomerization

  2016cited by this paper
• Acyldepsipeptide antibiotics kill mycobacteria by preventing the physiological functions of the ClpP1P2 protease

  2016cited by this paper
• RETRACTED ARTICLE: Culture of previously uncultured members of the human gut microbiota by culturomics

  2016cited by this paper
• Dual Targeting of Cell Wall Precursors by Teixobactin Leads to Cell Lysis

  2016cited by this paper
• Novel Culturing Techniques Select for Heterotrophs and Hydrocarbon Degraders in a Subantarctic Soil

  2016cited by this paper
• Antibiotic Resistance and Regulation of the Gram-Negative Bacterial Outer Membrane Barrier by Host Innate Immune Molecules

  2016cited by this paper
• Culture-independent discovery of natural products from soil metagenomes

  2016cited by this paper
• IMG-ABC: new features for bacterial secondary metabolism analysis and targeted biosynthetic gene cluster discovery in thousands of microbial genomes

  2016cited by this paper
• High-Throughput Single-Cell Cultivation on Microfluidic Streak Plates

  2016cited by this paper
• The healthy human microbiome

  2016cited by this paper
• Natural Products as a Source for Novel Antibiotics.

  2016cited by this paper
• A new antibiotic kills pathogens without detectable resistance

  2015cited by this paper
• Genomes to natural products PRediction Informatics for Secondary Metabolomes (PRISM)

  2015cited by this paper
• The Rebirth of Culture in Microbiology through the Example of Culturomics To Study Human Gut Microbiota

  2015cited by this paper
• Nutrient Limitation Governs Staphylococcus aureus Metabolism and Niche Adaptation in the Human Nose

  2014cited by this paper
• A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics.

  2014cited by this paper
• Antimicrobial peptides: new drugs for bad bugs?

  2014cited by this paper

• Editorial: Perspectives in clinical microbiology for combating multi-drug resistant bacterial infections: 2024/2025

  2026cites this paper